MapNeuro, Inc.

MapNeuro uses molecular methods to generate brain-wide maps of neuronal connectivity and gene expression at the cellular level. MapNeuro is now using these technologies to build a new in-vivo discovery platform for neurodegenerative and psychiatric disease.

MapNeuro, Inc. operates in prime based in Greater New York Area, East Coast, Northeastern US, founded in 2018.

Within the prime space, the company focuses on its core offering rather than a broad product line.

The business is associated with Greater New York Area, East Coast, Northeastern US.

Directory data places it at the Non_Equity_Assistance stage.

The company reports a headcount in the c_00001_00010 range.

Website: mapneuro.com